Katrin Sak

Summary

Country: Belgium

Publications

  1. ncbi request reprint Involvement of P2Y receptors in the differentiation of haematopoietic cells
    Katrin Sak
    Hematology Oncology Clinic, University of Tartu, Estonia
    J Leukoc Biol 73:442-7. 2003
  2. ncbi request reprint A retrospective of recombinant P2Y receptor subtypes and their pharmacology
    Katrin Sak
    Hematology Oncology Clinic, Tartu University, Ulikooli 18, Tartu 50090, Estonia
    Arch Biochem Biophys 397:131-6. 2002
  3. pmc Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor
    Yong Chul Kim
    Laboratory of Drug Discovery, Department of Life Science, Gwangju Institute of Science and Technology, 1 Oryong dong, Buk Gu, Gwangju 500 712, Republic of Korea
    Biochem Pharmacol 70:266-74. 2005
  4. ncbi request reprint Neuronal and glial cell lines as model systems for studying P2Y receptor pharmacology
    Katrin Sak
    Rudolf Boehm Institute of Pharmacology and Toxicology, and Interdisciplinary Center for Clinical Research, Medical Faculty, University of Leipzig, D 04107 Leipzig, Germany
    Neurochem Int 47:401-12. 2005

Collaborators

Detail Information

Publications4

  1. ncbi request reprint Involvement of P2Y receptors in the differentiation of haematopoietic cells
    Katrin Sak
    Hematology Oncology Clinic, University of Tartu, Estonia
    J Leukoc Biol 73:442-7. 2003
    ..It is suggested that the role of P2Y receptors in the maturation of blood cells may be more important than believed so far...
  2. ncbi request reprint A retrospective of recombinant P2Y receptor subtypes and their pharmacology
    Katrin Sak
    Hematology Oncology Clinic, Tartu University, Ulikooli 18, Tartu 50090, Estonia
    Arch Biochem Biophys 397:131-6. 2002
    ..In this article a review of the P2Y receptor subtypes is presented considering both their sequences and the pharmacological profiles of the encoded receptors expressed in heterologous expression systems...
  3. pmc Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor
    Yong Chul Kim
    Laboratory of Drug Discovery, Department of Life Science, Gwangju Institute of Science and Technology, 1 Oryong dong, Buk Gu, Gwangju 500 712, Republic of Korea
    Biochem Pharmacol 70:266-74. 2005
    ..Thus, MRS2211 displayed >20-fold selectivity as antagonist of the P2Y13 receptor in comparison to P2Y1 and P2Y12 receptors, while MRS2603 antagonized both P2Y1 and P2Y13 receptors...
  4. ncbi request reprint Neuronal and glial cell lines as model systems for studying P2Y receptor pharmacology
    Katrin Sak
    Rudolf Boehm Institute of Pharmacology and Toxicology, and Interdisciplinary Center for Clinical Research, Medical Faculty, University of Leipzig, D 04107 Leipzig, Germany
    Neurochem Int 47:401-12. 2005
    ..The variability of receptor expression profiles in established cell lines is further discussed, bringing forward some general properties for neuronal and glial malignant cell lines...